Ron Cohen
2017
In 2017, Ron Cohen earned a total compensation of $2M as President and Chief Executive Officer at Acorda Therapeutics, a 41% decrease compared to previous year.
Compensation breakdown
| Option Awards | $395,718 |
|---|---|
| Salary | $791,813 |
| Stock Awards | $821,503 |
| Other | $7,950 |
| Total | $2,016,984 |
Cohen received $821.5K in stock awards, accounting for 41% of the total pay in 2017.
Cohen also received $395.7K in option awards, $791.8K in salary and $8K in other compensation.
Rankings
In 2017, Ron Cohen's compensation ranked 5,460th out of 14,666 executives tracked by ExecPay. In other words, Cohen earned more than 62.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,460 out of 14,666 | 63rd |
Division Manufacturing | 1,963 out of 5,772 | 66th |
Major group Chemicals And Allied Products | 589 out of 2,075 | 72nd |
Industry group Drugs | 452 out of 1,731 | 74th |
Industry Biological Products, Except Diagnostic Substances | 82 out of 313 | 74th |
Source: SEC filing on April 27, 2018.
Cohen's colleagues
We found five more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2017.
2017
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
2017
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2017
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2017
Jane Wasman
Acorda Therapeutics
General Counsel
2017
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019